Skip to content

Evaluation of the acute- and long-term results after endovascular therapy of the popliteal artery

Evaluation of the acute- and long-term results after endovascular therapy of the popliteal artery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00019096
Enrollment
400
Registered
2019-11-08
Start date
2019-07-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I70.22

Interventions

Group 1: Endovascular therapy (balloon angioplasty, stent angioplasty, drug-coated balloon angioplasty, drug-coated stent angioplasty, atherectomy) of arteriosclerotically caused stenosis of the popli

Sponsors

Universitäts-Herzzentrum Bad Krozingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: - Patients with peripheral arterial occlusive disease in clinical stage 1-3 according to Rutherford-Becker classification. - De-novo stenosis caused by arteriosclerotic disease (=70% diameter reduction) or occlusion of the popliteal artery, duplex sonographically and/or angiographically confirmed. - Stenosis or occlusion of the popliteal artery which not include the superficial femoral artery and/or the anterior tibial artery and/or the tibiofibular truncus. - At least one open, non-stenosed (=50% diameter reduction) lower leg artery on the study leg. - At least one follow-up examination (including duplex sonography) in a period of at least 12 months after the index procedure.

Exclusion criteria

Exclusion criteria: - Patients with PAD in stage 0, 4 - 6 according to Rutherford-Becker classification. - Stenosis or occlusion of the poplitea artery not due to arteriosclerotic causes. - No relevant stenosis of the target lesion (7mm) - Unsuccessful intervention of the target lesion (remaining residual stenosis =30%) - Re-stenosis or re-occlusion of the target lesion after previous surgical and/or endovascular therapy. - Treated target lesion of the poplitea artery extends to the superficial femoral artery and/or the antior tibial artery and/or the tibiofibular truncus. - Occlusion or relevant stenosis (>50% diameter reduction) of all lower leg arteries. - Limited renal function (creatinine =2.4mg/dl) or terminal renal insufficiency requiring dialysis during index procedure. - No follow-up imaging (duplex sonography or angiography) of the target lesion at least 12 months after the index procedure (lost-to-follow-up).

Design outcomes

Primary

MeasureTime frame
Freedom from target lesion revascularization (TLR)

Secondary

MeasureTime frame
Secondary Patency rate of the target lesion - Time to first re-intervention at the target lesion. - Minor and/or major amputation of the treated leg - Leg survival rate - Change in clinical symptoms based on the Rutherford-Becker classification. - Severe cardiovascular events (myocardial infarction, stroke, major amputation, death)

Countries

Germany

Contacts

Public ContactThomas Zeller

Universitäts-Herzzentrum Bad Krozingen

Thomas.Zeller@universitaets-herzzentrum.de004976334020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026